Alternative Cancer Treatment, Cancer Research

Google Files a New Patent For a Wearable Cancer Treatment

Advances In Genetics
Advanced Cancer Research

Cancer researchers have been working on coming up with better ways to detect and treat cancer for years. Now, thanks to the work of inventor and cell biologist Dr. Andrew Conrad, the combination of nanotechnology and Google technology has the potential to find and destroy cancer cells in the near future.

Biology Meets Technology

In the latest cancer news, tech giant Google announced a new patent for a wearable device that can detect cancer cells and potentially get rid of them. The device is designed to be worn on the wrist and works with a pill containing magnetic nanoparticles. The device projects a magnetic field that draws the nanoparticles and any cells that are targeted, such as cancerous cells. The nanoparticles are meant to latch onto the targeted cells and draw them toward the device, which then creates and sends energy to blood vessels. Theoretically, this process would result in the cancerous cells being changed into harmless ones or destroyed altogether.

Worth the Wait

Google’s wearable device is still pending approval by the FDA and isn’t expected to be out for five years or more, but it could eventually give hope to those who are either at risk of cancer or those who want an alternative, non-toxic way to treat cancer. The device would provide a convenient and non-invasive way to fight cancer. It could also end up being used to target harmful abnormal cells associated with several other diseases, including Parkinson’s disease and HIV.

If you would like more information on non-toxic forms of treatment for cancer, please contact Issels®. We offer a wide range of Integrative Immunotherapy Programs, as well as cancer vaccines.

Alternative Cancer Treatment, Cancer Research

TGen Study Looks at Cancer Tumor Cloaking Materials

image of cells
Tripping Down To The Cancer

Treating cancer is difficult enough without the cancer cells hiding behind an extra layer of cellular material called stroma. Researchers at Translational Genomics Research Institute (TGen) believe drugs that strip away that stroma could improve the effectiveness of cancer drugs. At Issels® Integrative Immuno-Oncology, we understand complexities of effective cancer treatment. That is why our personalized, non-toxic treatments are based on extensive clinical and scientific research.

The TGen study

The TGen researchers state that breaking down that stroma could significantly extend the life of cancer patients, even those with late stage cancer that has already spread to some of their other organs. The stroma is made up of hyaluronan and various other types of collagen. It impedes anti-cancer drugs from finding their targeted cancer cells. The TGen researchers noticed a correlation between higher levels stroma and poor survival rates among patients with pancreatic cancer.

Pancreatic cancer

The pancreas is located behind the stomach. It is responsible for producing essential digestive juices and other necessary hormones. Each year, approximately 49,000 people in the U.S. are diagnosed with pancreatic cancer. Over 40,000 will die, making it the fourth deadliest cancer in America. The median survival time for people with advanced pancreatic cancer is 6 months from diagnosis. Less than six percent live five or more years after the diagnosis.

Dr. Daniel D. Von Hoff, who authored the TGen study, believes therapies that target stroma could lead to much better survival rates.

We want to keep you updated on the latest cancer research and provide the information you need to make informed decisions about your cancer treatment. Visit the Issels® website and sign up for our free e-Newsletter.

Alternative Cancer Treatment, Cancer Research, News

Bayer Give $1 Million to Aid in Cancer Information Technology Platform

Stack of Money
Big Donations

Here at Issels® whenever we hear a great piece of cancer news, we’re always excited to share it. According to a recent news article, Bayer HealthCare, one of the giants in the world of healthcare, has contributed one million dollars toward funding for CancerLinQ.

Advances in technology have paved the way for improved cancer treatments in recent years, and CancerLinQ is no exception. Experts believe that this technological platforms is going to be very instrumental in unlocking information about patients who are living with cancer. This information can then be used to alter the quality of care cancer patients receive, as well as work towards developing more personalized treatments for them.

Once data has been captured from current cancer patients, as well as from their caregivers, CancerLinQ goes to work on their individual needs and experiences. This is a revolutionary concept that has the ability to improve care for everyone who is affected by a cancer diagnosis.

Bayer Healthcare has been committed to cancer research for years. Their oncology franchise includes three products and many compounds that are currently being developed. It is exciting to see that they have partnered with the Conquer Cancer Foundation and the American Society of Clinical Oncology, and it will be even more exciting to see how CancerLinQ changes the quality of care for cancer patients in the years ahead.

A cancer diagnosis can change so many parts of your life, but your road to remission doesn’t have to be paved with uncertainty and pain. Here at Issels®, we view cancer treatment and patients very differently. We would love to talk to you about alternative treatment options. Please contact us.

Alternative Cancer Treatment, Stage Four Cancer Treatment

The Realities of Living with Stage 4 Breast Cancer

Breast Cancer Awareness
Stage 4 Breast Cancer

While organizations like Susan G. Komen have promoted the importance of early detection in defeating breast cancer, there is another group that struggles to be heard. Women with Stage 4 metastatic breast cancer (MBC) are working to educate the public about the realities of living with what they refer to as “mets”.

Treating MBC

Cancer becomes metastatic when it travels through the blood to create tumors in the lungs, liver and other parts of the body. Between 20 and 30 percent of women who are diagnosed with early stage breast cancer will develop MBC, which is treatable but not curable.

Jody Schoger, an MBC patient and cancer awareness advocate, explains the difference in philosophy for treating both types. She says that when she received her initial diagnosis, her doctors pulled out all the stops in an attempt to put the tumor in permanent remission. With MBC, however, the best they can hope for is to stabilize the disease so they use a minimum of treatment needed to obtain the maximum effect.

Misconceptions about MBC

Women with MBC are frustrated that the focus on “survivorship” has resulted in a number of erroneous concepts about the disease. Pfizer Oncology surveyed 2,000 people on the topic and found that 60 percent of respondents knew little to nothing about MBC and 50 percent believed that it was a result of patients not taking care of themselves.

At Issels® we see you as an individual, not as your disease. Our treatments are personalized to address your particular needs. Contact us to learn more about our non-toxic alternative treatment program.

Alternative Cancer Treatment, Cancer Research, Immunotherapy

Brain Cancer Immunotherapy Boosted by Tetanus Vaccine

Doctor
Brain Cancer Discoveries

Cancer vaccines train the body’s immune system to target and kill cancer cells, often requiring a boost to the patient’s immune power. A recent study has found a surprising teammate for brain cancer vaccines: the tetanus shot.

The same tetanus vaccine used to prevent bacterial infections associated with rusted metal has a powerful effect of activating and alerting the body’s immune system overall. Because of this, the boost from a tetanus shot may be an extremely effective tool in increasing the success of immunotherapy treatments.

Doctors at Duke University Medical Center recently administered a cancer vaccine trial to patients with glioblastoma, an aggressive type of brain tumor. In patients who first received the tetanus shot to awaken their immune response, survival rates increased significantly.

Here’s what the 12-patient trial study found:

  • Patients given tetanus and cancer vaccines survived 4 to 8 more years, with one patient still surviving. Patients without the tetanus vaccine survived up to 11 months.
  • The tetanus vaccine sounds a warning call to the body’s immune system. This increases the chances that the cancer vaccine will be successfully received by the lymph nodes — where the cancer vaccine must go to train the immune system.
  • The cytomegalovirus — present in most people but inactive — becomes reactivated in brain cancer cells. The dendritic cells cancer vaccine can identify brain cancer cells by looking for active cytomegalovirus.

Researchers hope that the tetanus vaccine can not only be a successful tool to fight glioblastoma brain cancer, but also teach us how to boost other kinds of cancer immunotherapy.

Contact us at Issels® Integrative Immuno-Oncology to find out about cancer vaccines and other innovative forms of immunotherapy.

Cancer Care Tips

Don’t Say These Things When Your Loved One is Going Through Chemo

When a Caregiver Gets Cancer
Tips For Talking To Cancer Patients

Having a hard time taking part in an unconstrained conversation with a loved one who is undergoing chemotherapy cancer treatment? Issels® wants to help you avoid opening your mouth and inserting your foot.

Are you making these chemo conversational faux pas?

  • “You look great!”
    Patients puffy from steroids, sporting bald spots and raccoon eyes know this is phony baloney. Try for a, “Good to see you!” or a specific compliment pertaining to an outfit or piece of jewelry instead.
  • “When my friend So-and-so went through chemo…”
    You may be looking for a way to connect, but bringing up the chemo experiences of others is not a comfort. Your loved one may feel their feelings have been disregarded. Worse, they may experience anxiety regarding their much different chemo experience. Unless your comment involves a friend who is now living a happy, healthy life, keep it to yourself.
  • “I don’t know why you’re doing _______ anymore.”
    Negative thoughts can take a toll on your loved one’s immune system. Don’t make assumptions on what they can handle or put a timeline on activities. This can spotlight limitations and death. Encourage loved ones to develop new interests and friends instead, which puts the emphasis on survival.
  • “I’m so worried about you!”
    Anxiety is contagious. Keep stress-inducing thoughts to yourself.
  • “Chemo must be so hard! Do you feel sick?”
    Your loved one is already feeling down. Offer upbeat comments instead: “I’m so thankful the chemo is helping you get better.”

Are you or a loved one looking cancer treatment in the eye? We know how to handle it. Contact Issels®  today to learn more about alternative treatment options available to you.

Individualized Cancer Treatment